The treatment of nephrotic syndrome caused by primary (light chain) amyloid with vincristine, doxorubicin and dexamethasone.

por Wardley, A. M., Jayson, G. C., Goldsmith, D. J., Venning, M. C., Ackrill, P., Scarffe, J. H.
Publicado 1998

Management of cardiac health in trastuzumab-treated patients with breast cancer: updated United Kingdom National Cancer Research Institute recommendations for monitoring

por Jones, A L, Barlow, M, Barrett-Lee, P J, Canney, P A, Gilmour, I M, Robb, S D, Plummer, C J, Wardley, A M, Verrill, M W
Publicado 2009

tAnGo: a randomised phase III trial of gemcitabine in paclitaxel-containing, epirubicin/cyclophosphamide-based, adjuvant chemotherapy for early breast cancer: a prospective pulmona...

por Wardley, A M, Hiller, L, Howard, H C, Dunn, J A, Bowman, A, Coleman, R E, Fernando, I N, Ritchie, D M, Earl, H M, Poole, C J
Publicado 2008

Incidence of cerebral metastases in patients treated with trastuzumab for metastatic breast cancer

por Clayton, A J, Danson, S, Jolly, S, Ryder, W D J, Burt, P A, Stewart, A L, Wilkinson, P M, Welch, R S, Magee, B, Wilson, G, Howell, A, Wardley, A M
Publicado 2004

The UK national breast cancer screening programme for survivors of Hodgkin lymphoma detects breast cancer at an early stage

por Howell, S J, Searle, C, Goode, V, Gardener, T, Linton, K, Cowan, R A, Harris, M A, Hopwood, P, Swindell, R, Norman, A, Kennedy, J, Howell, A, Wardley, A M, Radford, J A
Publicado 2009